Keystone Financial Group »

Emergent BioSolutions shares owned by Keystone Financial Group

Quarter-by-quarter ownership of Emergent BioSolutions (EBS) shares owned by Keystone Financial Group from 13F filings

Historical chart of Keystone Financial Group investment in Emergent BioSolutions

Tip: Access up to 7 years of quarterly data

All positions including Emergent BioSolutions held by Keystone Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Emergent BioSolutions by Keystone Financial Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $276k 31k 8.82
2025-06-30 $194k 30k 6.38
2025-03-31 $91k 19k 4.86

More positions owned by Keystone Financial Group

Spdr S&p 500 Etf MF Closed and MF Open (SPY)
Apple Common Stock (AAPL)
Palantir Technologies Common Stock (PLTR)
Nvidia Corp Common Stock (NVDA)
Vanguard Total MF Closed and MF Open (VTI)
Spdr Portfolio MF Closed and MF Open (SPLG)
Tesla Common Stock (TSLA)
Spdr Portfolio MF Closed and MF Open (SPYG)
Victoryshares Free MF Closed and MF Open (VFLO)
Microsoft Corp Common Stock (MSFT)
Ishares U S MF Closed and MF Open (DYNF)
Meta Platforms Common Stock (META)
Amazon Common Stock (AMZN)
Vanguard S&p 500 Etf MF Closed and MF Open (VOO)
Berkshire Hathaway Class Class B Common Stock (BRK.B)

View all positions for Keystone Financial Group

Top funds holding Emergent BioSolutions

BlackRock
Oak Hill Advisors
Vanguard Group
State Street Corporation
American Century Companies
Dimensional Fund Advisors
Palisade Capital Management
Charles Schwab Investment Management
Geode Capital Management
Acadian Asset Management
Connor, Clark & Lunn Investment Management
Marshall Wace
LSV Asset Management
Prescott Group Capital Management
Morgan Stanley

View all funds holding Emergent BioSolutions